News

Winstone’s Voice

Winstone in Seattle, 2005

As has been widely reported, we lost Winstone Zulu, a tireless advocate for TB/HIV (see more info at the TB Alliance and ACTION). I was lucky to have been able to work with Winstone over the years – his greeting was always a hearty: “So when are you coming to Zambia?” I had to laugh because he always seemed to be everywhere all at once, on a tireless global journey to promote TB/HIV awareness.

But he was tired – often exhausted from battling his illness, adverse reactions to therapy, and of course his punishing schedule. And yet, to know him was to marvel at his indomitable spirit, which rarely seemed to miss an opportunity to do some good in the world.

Chief among Winstone’s gifts was the ability to speak with passion about his subject, finding the precise balance between hard facts, personal history, and an inspiring call to action. In 2003, we collaborated on a video to raise awareness about TB/HIV co-infection. The title, “Winstone Zulu is Alive” came from a conversation in which Winstone explained that since the average life expectancy in Zambia was 40 (his figure), he was already living on borrowed time and it was important to remind people that he was still around.

Now that Winstone has passed, the title seems all the more poignant: if you listen to his profoundly moving voice, you realize that his spirit remains very much with us.

John-Michael Maas

Winstone Zulu boarding a ferry in Seattle, 2005

Make a donation to support Winstone’s family

RESULTS has set up an account to make donations to help support Winstone’s family. In order to alert RESULTS that your contribution is for the Winstone Zulu Memorial Fund, you must copy and paste “Winstone Zulu Memorial Fund” into the field that asks, “Who invited you to give to us?” Click here to make a donation.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...